GCT
GigaCloud Technology Inc.
GCT's outlook is improving, though it still trails on the overall score.
NVDA
NVIDIA Corporation
NVDA has the edge over GCT overall, supported by stronger valuation and stronger modeled upside.
GCT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Strong |
GCT's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
GCT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.7x | $31.18 | -52% |
| Fair | 9.6x | $44.23 | -32% |
| Forward | 12x | $64.79 | — |
| Expensive | 13x | $58.32 | -10% |
| Current | 14x | $64.79 | — |
Historical ranges are pointers, not guarantees.
GCT's PE is in its expensive range at 14x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over GCT in the historical PE scenario, which offers more potential upside but is not a forecast.
GCT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
GCT has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
GCT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.61 | +21% |
| Q3 2026 | $4.62 | +38% |
| Q2 2026 | $4.20 | +26% |
| Q1 2026 | $3.95 | +29% |
| Q4 2025 | $3.59 | +18% |
| Q3 2025 | $3.34 | +5.7% |
| Q2 2025 | $3.33 | +20% |
| Q1 2025 | $3.07 | +19% |
| Q4 2024 | $3.05 | +33% |
GCT's earnings per share have climbed steadily: $4.62 over the past year, up 38% from the year before, and higher year over year for 15 quarters in a row.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over GCT on earnings, with stronger typical year-over-year growth.
GCT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $423.6M | +27% |
| Q2 2026 | $411.6M | +28% |
| Q1 2026 | $359.5M | +32% |
| Q4 2025 | $362.7M | +23% |
| Q3 2025 | $332.6M | +9.7% |
| Q2 2025 | $322.6M | +3.8% |
| Q1 2025 | $271.9M | +8.3% |
| Q4 2024 | $295.8M | +21% |
GCT's revenue has grown year over year every quarter since early 2021: $424M last quarter, up 27% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +1.8 points |
| Q2 2026 | 12% | +0.4 points |
| Q1 2026 | 12% | +1.4 points |
| Q4 2025 | 11% | +1.8 points |
| Q3 2025 | 12% | -1.3 points |
| Q2 2025 | 11% | +2.3 points |
| Q1 2025 | 10% | -3.4 points |
| Q4 2024 | 9.3% | -5.8 points |
GCT's operating margin was 14% last quarter, up 1.8 points from the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over GCT on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over GCT on profitability, with a higher operating margin.
GCT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $55.8M | -28% |
| Q2 2026 | $45.1M | +22% |
| Q1 2026 | -$26.2M | -472% |
| Q4 2025 | $61.7M | -7.9% |
| Q3 2025 | $77.1M | +50% |
| Q2 2025 | $37M | +187% |
| Q1 2025 | $7M | -38% |
| Q4 2024 | $66.9M | +42% |
GCT generated $136M in free cash flow over the past year, down 27% from the year before.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over GCT on cash flow, with more consistent year-over-year improvement.
GCT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2% | -722K shares |
| 1 year | -4.7% | -1.8M shares |
| 3 years | -12% | -5.1M shares |
| 5 years | -11% | -4.4M shares |
| Available history | +277% | +26.3M shares |
GCT has the edge over NVDA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $17.7M |
| Q2 2026 | $30M |
| Q1 2026 | $12.3M |
| Q1 2025 | $22.7M |
| Q4 2024 | $23.2M |
| Q4 2023 | — |
| Q3 2023 | $1.5M |
| Q2 2023 | — |
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has 24.3B diluted shares, down 1% from a year ago, with $55.3B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
GCT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.9x | Net Cash |
| Q2 2026 | -1.9x | Net Cash |
| Q1 2026 | -2.0x | Net Cash |
| Q4 2025 | -2.5x | Net Cash |
| Q3 2025 | -2.4x | Net Cash |
| Q2 2025 | -1.7x | Net Cash |
| Q1 2025 | -1.9x | Net Cash |
| Q4 2024 | -1.9x | Net Cash |
GCT has the edge over NVDA on leverage, with a lower net debt burden relative to earnings.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
GCT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 75.7 | Overbought |
| Stochastic | 79.3 | Neutral |
GCT's weekly RSI is 76 (overbought) and its Stochastic is 79 (neutral).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
GCT PE vs Technology Sector
| Metric | GCT | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 28x | 50% below |
| PE % | 91 | 43 | 48 pts above |
GCT has the edge over NVDA on valuation relative to its sector.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
GCT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $57.8 | 12% above |
| 20 week MA | $50.6 | 28% above |
| 50 week MA | $44.2 | 46% above |
| 100 week MA | $33.1 | 96% above |
| 200 week MA | $25.6 | 153% above |
GCT has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
GCT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $48.0 | $5.53 | -88% |
| 2023 | $5.53 | $18.3 | +231% |
| 2024 | $18.3 | $17.6 | -4% |
| 2025 | $17.6 | $40.2 | +129% |
| 2026 YTD | $40.2 | $64.8 | +61% |
GCT has the edge over NVDA on returns for 2026, with the stronger performance.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.